-
1
-
-
0141642224
-
Medicine. The NIH Roadmap
-
10.1126/science.1091867 14526066
-
Zerhouni E Medicine. The NIH Roadmap Science 2003, 302:63-72 10.1126/ science.1091867 14526066
-
(2003)
Science
, vol.302
, pp. 63-72
-
-
Zerhouni, E.1
-
2
-
-
26444505936
-
Translational and clinical science - Time for a new vision
-
10.1056/NEJMsb053723 16221788
-
Zerhouni EA Translational and clinical science - time for a new vision N Engl J Med 2005, 353:1621-1623 10.1056/NEJMsb053723 16221788
-
(2005)
N Engl J Med
, vol.353
, pp. 1621-1623
-
-
Zerhouni, E.A.1
-
3
-
-
2642579960
-
The Child and Adolescent Psychiatry Trials Network (CAPTN)
-
10.1097/00004583-200405000-00004 15100557
-
March JS Silva SG Compton S Anthony G DeVeaugh-Geiss J Califf R Krishnan R The Child and Adolescent Psychiatry Trials Network (CAPTN) J Am Acad Child Adolesc Psychiatry 2004, 43:515-518 10.1097/ 00004583-200405000-00004 15100557
-
(2004)
J Am Acad Child Adolesc Psychiatry
, vol.43
, pp. 515-518
-
-
March, J.S.1
Silva, S.G.2
Compton, S.3
Anthony, G.4
DeVeaugh-Geiss, J.5
Califf, R.6
Krishnan, R.7
-
4
-
-
33645100012
-
Child and adolescent psychopharmacology in the new millennium: A workshop for academia, industry, and government
-
10.1097/01.chi.0000194568.70912.ee 16540810
-
DeVeaugh-Geiss J March J Shapiro M Andreason PJ Emslie G Ford LM Greenhill L Murphy D Prentice E Roberts R Silva S Swanson JM van Zwieten-Boot B Vitiello B Wagner KD Mangum B Child and adolescent psychopharmacology in the new millennium: A workshop for academia, industry, and government J Am Acad Child Adolesc Psychiatry 2006, 45:261-270 10.1097/01.chi.0000194568.70912.ee 16540810
-
(2006)
J Am Acad Child Adolesc Psychiatry
, vol.45
, pp. 261-270
-
-
DeVeaugh-Geiss, J.1
March, J.2
Shapiro, M.3
Andreason, P.J.4
Emslie, G.5
Ford, L.M.6
Greenhill, L.7
Murphy, D.8
Prentice, E.9
Roberts, R.10
Silva, S.11
Swanson, J.M.12
van Zwieten-Boot, B.13
Vitiello, B.14
Wagner, K.D.15
Mangum, B.16
-
6
-
-
0027872361
-
Large-scale randomized evidence: Large, simple trials and overviews of trials
-
10.1111/j.1749-6632.1993.tb26369.x 8192313
-
Peto R Collins R Gray R Large-scale randomized evidence: Large, simple trials and overviews of trials Ann N Y Acad Sci 1993, 703:314-340 10.1111/j.1749-6632.1993.tb26369.x 8192313
-
(1993)
Ann N Y Acad Sci
, vol.703
, pp. 314-340
-
-
Peto, R.1
Collins, R.2
Gray, R.3
-
7
-
-
0032585233
-
Trials: The next 50 years. Large scale randomised evidence of moderate benefits [editorial] [see comments]
-
[editorial] [see comments] 1114150 9794846
-
Peto R Baigent C Trials: The next 50 years. Large scale randomised evidence of moderate benefits [editorial] [see comments] Bmj 1998, 317:1170-1171 1114150 9794846
-
(1998)
Bmj
, vol.317
, pp. 1170-1171
-
-
Peto, R.1
Baigent, C.2
-
8
-
-
0141684982
-
Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy
-
10.1001/jama.290.12.1624 14506122
-
Tunis SR Stryer DB Clancy CM Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy Jama 2003, 290:1624-1632 10.1001/jama.290.12.1624 14506122
-
(2003)
Jama
, vol.290
, pp. 1624-1632
-
-
Tunis, S.R.1
Stryer, D.B.2
Clancy, C.M.3
-
9
-
-
0037031257
-
Lessons learned from recent cardiovascular clinical trials: Part I
-
10.1161/01.CIR.0000023219.51483.66 12163438
-
DeMets DL Califf RM Lessons learned from recent cardiovascular clinical trials: Part I Circulation 2002, 106:746-751 10.1161/ 01.CIR.0000023219.51483.66 12163438
-
(2002)
Circulation
, vol.106
, pp. 746-751
-
-
DeMets, D.L.1
Califf, R.M.2
-
10
-
-
0037072462
-
Lessons learned from recent cardiovascular clinical trials: Part II
-
10.1161/01.CIR.0000023220.26465.89 12176964
-
DeMets DL Califf RM Lessons learned from recent cardiovascular clinical trials: Part II Circulation 2002, 106:880-886 10.1161/ 01.CIR.0000023220.26465.89 12176964
-
(2002)
Circulation
, vol.106
, pp. 880-886
-
-
DeMets, D.L.1
Califf, R.M.2
-
11
-
-
0042783158
-
(TADS): Rationale, design, and methods
-
TADS Treatment for Adolescents With Depression Study 10.1097/ 01.CHI.0000046839.90931.0D 12707557
-
TADS Treatment for Adolescents With Depression Study (TADS): Rationale, design, and methods J Am Acad Child Adolesc Psychiatry 2003, 42:531-542 10.1097/01.CHI.0000046839.90931.0D 12707557
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 531-542
-
-
-
12
-
-
4043156247
-
Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial
-
TADS 10.1001/jama.292.7.807 15315995
-
TADS Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial Jama 2004, 292:807-820 10.1001/ jama.292.7.807 15315995
-
(2004)
Jama
, vol.292
, pp. 807-820
-
-
-
13
-
-
0034942329
-
Routine outcome measurement in a child and adolescent mental health service: An evaluation of HoNOSCA. The Health of the Nation Outcome Scales for Children and Adolescents
-
10.1046/j.1440-1614.2001.00890.x 11437812
-
Brann P Coleman G Luk E Routine outcome measurement in a child and adolescent mental health service: An evaluation of HoNOSCA. The Health of the Nation Outcome Scales for Children and Adolescents Aust N Z J Psychiatry 2001, 35:370-376 10.1046/j.1440-1614.2001.00890.x 11437812
-
(2001)
Aust N Z J Psychiatry
, vol.35
, pp. 370-376
-
-
Brann, P.1
Coleman, G.2
Luk, E.3
-
14
-
-
0033924174
-
Child and adolescent mental health service use. HoNOSCA as an outcome measure
-
10.1192/bjp.177.1.52 10945089
-
Garralda ME Yates P Higginson I Child and adolescent mental health service use. HoNOSCA as an outcome measure Br J Psychiatry 2000, 177:52-58 10.1192/bjp.177.1.52 10945089
-
(2000)
Br J Psychiatry
, vol.177
, pp. 52-58
-
-
Garralda, M.E.1
Yates, P.2
Higginson, I.3
-
15
-
-
0032953766
-
Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). Glossary for HoNOSCA score sheet
-
10.1192/bjp.174.5.428 10616610
-
Gowers SG Harrington RC Whitton A Beevor A Lelliott P Jezzard R Wing JK Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). Glossary for HoNOSCA score sheet Br J Psychiatry 1999, 174:428-431 10.1192/bjp.174.5.428 10616610
-
(1999)
Br J Psychiatry
, vol.174
, pp. 428-431
-
-
Gowers, S.G.1
Harrington, R.C.2
Whitton, A.3
Beevor, A.4
Lelliott, P.5
Jezzard, R.6
Wing, J.K.7
-
16
-
-
0036511355
-
Use of a routine, self-report outcome measure (HoNOSCA-SR) in two adolescent mental health services. Health of the Nation Outcome Scale for Children and Adolescents
-
10.1192/bjp.180.3.266 11872520
-
Gowers S Levine W Bailey-Rogers S Shore A Burhouse E Use of a routine, self-report outcome measure (HoNOSCA-SR) in two adolescent mental health services. Health of the Nation Outcome Scale for Children and Adolescents Br J Psychiatry 2002, 180:266-269 10.1192/bjp.180.3.266 11872520
-
(2002)
Br J Psychiatry
, vol.180
, pp. 266-269
-
-
Gowers, S.1
Levine, W.2
Bailey-Rogers, S.3
Shore, A.4
Burhouse, E.5
-
17
-
-
15844400901
-
The Health of the Nation Outcome Scales for Children and Adolescents in an adolescent in-patient sample
-
10.1111/j.1440-1614.2005.01533.x 15701060
-
Harnett PH Loxton NJ Sadler T Hides L Baldwin A The Health of the Nation Outcome Scales for Children and Adolescents in an adolescent in-patient sample Aust N Z J Psychiatry 2005, 39:129-135 10.1111/ j.1440-1614.2005.01533.x 15701060
-
(2005)
Aust N Z J Psychiatry
, vol.39
, pp. 129-135
-
-
Harnett, P.H.1
Loxton, N.J.2
Sadler, T.3
Hides, L.4
Baldwin, A.5
-
18
-
-
0642281437
-
How can we improve the assessment of safety in child and adolescent psychopharmacology?
-
10.1097/01.CHI.0000046840.90931.36 12921470
-
Vitiello B Riddle MA Greenhill LL March JS Levine J Schachar RJ Abikoff H Zito JM McCracken JT Walkup JT Findling RL Robinson J Cooper TB Davies M Varipatis E Labellarte MJ Scahill L Capasso L How can we improve the assessment of safety in child and adolescent psychopharmacology? J Am Acad Child Adolesc Psychiatry 2003, 42:634-641 10.1097/ 01.CHI.0000046840.90931.36 12921470
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 634-641
-
-
Vitiello, B.1
Riddle, M.A.2
Greenhill, L.L.3
March, J.S.4
Levine, J.5
Schachar, R.J.6
Abikoff, H.7
Zito, J.M.8
McCracken, J.T.9
Walkup, J.T.10
Findling, R.L.11
Robinson, J.12
Cooper, T.B.13
Davies, M.14
Varipatis, E.15
Labellarte, M.J.16
Scahill, L.17
Capasso, L.18
-
19
-
-
0642311903
-
Review of safety assessment methods used in pediatric psychopharmacology
-
10.1097/01.CHI.0000046841.56865.37 12921469
-
Greenhill LL Vitiello B Riddle MA Fisher P Shockey E March JS Levine J Fried J Abikoff H Zito JM McCracken JT Findling RL Robinson J Cooper TB Davies M Varipatis E Labellarte MJ Scahill L Walkup JT Capasso L Rosengarten J Review of safety assessment methods used in pediatric psychopharmacology J Am Acad Child Adolesc Psychiatry 2003, 42:627-633 10.1097/01.CHI.0000046841.56865.37 12921469
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 627-633
-
-
Greenhill, L.L.1
Vitiello, B.2
Riddle, M.A.3
Fisher, P.4
Shockey, E.5
March, J.S.6
Levine, J.7
Fried, J.8
Abikoff, H.9
Zito, J.M.10
McCracken, J.T.11
Findling, R.L.12
Robinson, J.13
Cooper, T.B.14
Davies, M.15
Varipatis, E.16
Labellarte, M.J.17
Scahill, L.18
Walkup, J.T.19
Capasso, L.20
Rosengarten, J.21
more..
-
20
-
-
0642373283
-
Assessment of safety in pediatric psychopharmacology
-
10.1097/01.CHI.0000046843.56865.A5 12921468
-
Greenhill LL Assessment of safety in pediatric psychopharmacology J Am Acad Child Adolesc Psychiatry 2003, 42:625-626 10.1097/ 01.CHI.0000046843.56865.A5 12921468
-
(2003)
J Am Acad Child Adolesc Psychiatry
, vol.42
, pp. 625-626
-
-
Greenhill, L.L.1
-
21
-
-
45849152563
-
Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the Pediatric Adverse Event Rating Scale (PAERS)
-
10.1186/1753-2000-2-11
-
Wehmeier PM Schacht A Lehmann M Dittmann RW Silva SG March JS Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the Pediatric Adverse Event Rating Scale (PAERS) Child and adolescent psychiatry and mental health 2008, 2:11 10.1186/1753-2000-2-11
-
(2008)
Child and Adolescent Psychiatry and Mental Health
, vol.2
, pp. 11
-
-
Wehmeier, P.M.1
Schacht, A.2
Lehmann, M.3
Dittmann, R.W.4
Silva, S.G.5
March, J.S.6
-
23
-
-
34249333702
-
Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
-
10.1176/appi.ajp.164.7.1035 17606655
-
Posner K Oquendo MA Gould M Stanley B Davies M Columbia Classification Algorithm of Suicide Assessment (C-CASA): Classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants Am J Psychiatry 2007, 164:1035-1043 10.1176/appi.ajp.164.7.1035 17606655
-
(2007)
Am J Psychiatry
, vol.164
, pp. 1035-1043
-
-
Posner, K.1
Oquendo, M.A.2
Gould, M.3
Stanley, B.4
Davies, M.5
|